3rd Quarter - Report
INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH
Client
Income
$10,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
H.R. 1540 / S. 1253, National Defense Authorization Act, 2012, Title II, all provisions relating to infectious disease vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| AMANDA KING | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Budget/Appropriations BUD
H.R. 2219, Department of Defense Appropriations Act, 2012, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| AMANDA KING | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Government Issues GOV
Contacted Congressional offices regarding State Department programs for vaccine clinical trials, and to obtain letters of support for Aduro's competitive grant applications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| AMANDA KING | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.